Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Resomelagon methanesulfonate
Cat. No.:
OB0425LY-156
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Resomelagon methanesulfonate is a specific active melanocortin receptor (MR) agonist.
Synonyms:
2933183-20-9; AP1189 methanesulfonate
CAS No.:
2933183-20-9
Formula:
C15H18N6O5S
Formula Weight:
394.41
Specification
Target:
Melanocortin receptor; ERK
Pathway:
GPCR/G protein; Neuronal signaling; MAPK/ERK pathway; Stem cell/Wnt
Storage:
Storage at -20°C.
Applications:
Resomelagon methanesulfonate is mainly used in biomedical research, especially in the field of obesity, metabolic syndrome and other related areas involving the assessment of its efficacy and safety.
